Owczarek D - Search Results

1

Serum concentration of selected biochemical markers of endothelial dysfunction and inflammation in patients with the varying activity of inflammatory bowel disease.

Cibor D, Szczeklik K, Kozioł K, Pocztar H, Mach T, Owczarek D. Cibor D, et al. Among authors: owczarek d. Pol Arch Intern Med. 2020 Aug 27;130(7-8):598-606. doi: 10.20452/pamw.15463. Epub 2020 Jun 26. Pol Arch Intern Med. 2020. PMID: 32589376 Free article.

2

[Serum cytokine concentration as prognostic factor in patients with alcoholic liver disease].

Ciećko-Michalska I, Szczepanek M, Cibor D, Owczarek D, Skulina D, Szczepański W, Michalski M. Ciećko-Michalska I, et al. Among authors: owczarek d. Przegl Lek. 2006;63(5):249-52. Przegl Lek. 2006. PMID: 17036498 Polish.

3

Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms--a pilot study.

Cibor D, Ciećko-Michalska I, Owczarek D, Szczepanek M. Cibor D, et al. Among authors: owczarek d. Adv Med Sci. 2006;51:336-9. Adv Med Sci. 2006. PMID: 17357336 Clinical Trial.

4

Concomitant carcinoid tumor and papillary urothelial neoplasm of low malignant potential in a patient with Crohn's disease: a case report.

Owczarek D, Cibor D, Szczepański W, Kosowski B, Mach T. Owczarek D, et al. Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1231-4. doi: 10.1097/MEG.0b013e328302f484. Eur J Gastroenterol Hepatol. 2008. PMID: 18936711

5

Biological therapy of inflammatory bowel disease.

Owczarek D, Cibor D, Szczepanek M, Mach T. Owczarek D, et al. Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):84-8. Pol Arch Med Wewn. 2009. PMID: 19341184 Free article. Review.

6

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.

Owczarek D, Cibor D, Mach T. Owczarek D, et al. Inflamm Bowel Dis. 2010 Jan;16(1):52-7. doi: 10.1002/ibd.20994. Inflamm Bowel Dis. 2010. PMID: 19575355

7

Tissue factor -1208D>I polymorphism is associated with D-dimer levels in patients with inflammatory bowel disease.

Potaczek DP, Owczarek D, Cibor D, Nishiyama C, Okumura K, Mach T, Undas A. Potaczek DP, et al. Among authors: owczarek d. Inflamm Bowel Dis. 2010 Jul;16(7):1095-6. doi: 10.1002/ibd.21149. Inflamm Bowel Dis. 2010. PMID: 19856410 No abstract available.

8

An association between functional FceRIalpha polymorphisms and total serum IgE levels in patients with inflammatory bowel disease.

Potaczek DP, Owczarek D, Okumura K, Mach T, Undas A, Nishiyama C. Potaczek DP, et al. Among authors: owczarek d. Scand J Gastroenterol. 2010 Jun;45(6):766-7. doi: 10.3109/00365521003637229. Scand J Gastroenterol. 2010. PMID: 20163202 No abstract available.

9

[Inflammatory changes of oral cavity proceeding appearance of clinical symptoms of Crohn's disease].

Szczeklik K, Darczuk D, Owczarek D. Szczeklik K, et al. Among authors: owczarek d. Przegl Lek. 2010;67(12):1346-9. Przegl Lek. 2010. PMID: 21591368 Polish.

10

Met-enkephalins in patients with inflammatory bowel diseases.

Owczarek D, Cibor D, Mach T, Cieśla A, Pierzchała-Koziec K, Sałapa K, Kuśnierz-Cabała B. Owczarek D, et al. Adv Med Sci. 2011;56(2):158-64. doi: 10.2478/v10039-011-0051-x. Adv Med Sci. 2011. PMID: 22112433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page